Open Journal of Genetics

Volume 4, Issue 1 (March 2014)

ISSN Print: 2162-4453   ISSN Online: 2162-4461

Google-based Impact Factor: 0.21  Citations  

Prevalence of Human Leukocyte Antigen HLA-B*5701 in HIV-1 Infected Individuals in Brazil

HTML  Download Download as PDF (Size: 531KB)  PP. 56-62  
DOI: 10.4236/ojgen.2014.41008    4,427 Downloads   6,224 Views  Citations

ABSTRACT

This study was designed to establish the prevalence of HLA-B*5701 at HIV-1 infected individuals in Brazil. A total of 517 consecutive individuals were followed in this study from February 2009 through July 2011. The presence of HLA-B*5701 was determined by Nested-PCR with HLA-B*57 and HLA-B*5701 sequence-specific primers (PCR-SSP). The expression of HLA-B*57 was negative in the 385 (74.5%) and positive in the 103 (19.9%) of infected individuals. Among these, the expression of HLA-B5701 was positive in the 29 (5.6%) of individuals. No demographic or ethnic differences were found between HLA-B*57/HLA-B*5701 HIV-1 negative patients, with a prevalence of Caucasians (57.1%) individuals. During the period of study, 68 patients were submited to an abacavir contain- ing regimen. The HLA-B*5701 allele was observed in 7 (10.3%) patients, with a significant incidence of Hypersensitivity reactions at 4 of them (p < 0.001). Conclusions: Although Brazilian population consists of a mixture of individuals of Caucasian, African and Native American genetic background, prevalence of HLA-B*5701 in this population is similar to the one found in pure Caucasians.


Share and Cite:

Araújo, C. , Carvalho, C. , Souza Freire, M. , Yamaguti, A. , Scaff, I. , Souza, F. , Silvestre Silva, F. , Diaz, R. and Guerreiro da Silva, I. (2014) Prevalence of Human Leukocyte Antigen HLA-B*5701 in HIV-1 Infected Individuals in Brazil. Open Journal of Genetics, 4, 56-62. doi: 10.4236/ojgen.2014.41008.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.